Eli Lilly's stock rallies after a profit beat and raised outlook, although revenue fell short

Shares of Eli Lilly & Co. LLY, -5.49% rallied 2.6% in premarket trading Thursday, after the drug maker beat profit expectations and raised its full-year outlook, while revenue fell shy. Net income rose to $1.41 billion, or $1.55 a share, from $1.33 billion, or $1.44 a share, in the year-ago period.